echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Safety of Raloxifene

    The Safety of Raloxifene

    • Last Update: 2023-04-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Raloxifene, also known by its trade name Evista, is a medication that is primarily used to treat and prevent osteoporosis in postmenopausal women.
    It has also been shown to reduce the risk of breast cancer in women with a high risk of the disease.
    However, like all medications, raloxifene carries some risks and it is important to understand these risks in order to make informed decisions about its use.


    One of the main risks associated with raloxifene is an increased risk of deep vein thrombosis (DVT), which is a blood clot that forms in the deep veins of the body.
    This can be a serious condition, as blood clots can break loose and travel to the lungs, causing a pulmonary embolism.
    While the risk of DVT is generally low, it is higher in women taking raloxifene than in those not taking the medication.


    Another potential risk of raloxifene is an increased risk of breast cancer.
    While the medication is often prescribed to reduce the risk of breast cancer, it has been shown to have a small increased risk of developing this disease in some women.
    This increased risk is generally low, but it is important for women to discuss the potential risks and benefits of raloxifene with their doctor before deciding to take the medication.


    In addition to these specific risks, raloxifene, like all medications, carries a range of more general side effects.
    These can include hot flashes, joint pain, and sweating, among others.
    These side effects are generally mild, but they can be bothersome for some women.


    Overall, while raloxifene can be an effective medication for treating and preventing osteoporosis and reducing the risk of breast cancer in certain women, it is important to carefully weigh the potential risks and benefits of the medication before deciding to take it.
    Women who are considering taking raloxifene should discuss the potential risks and benefits of the medication with their doctor, as well as any other medications they are currently taking, in order to make an informed decision about its use.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.